Your browser doesn't support javascript.
Viral load of SARS-CoV-2 Omicron BA.5 is lower than that of BA.2 despite the higher infectivity of BA.5.
Takatsuki, Yuna; Takahashi, Yuta; Nakajima, Jun; Iwasaki, Yumi; Nagano, Katsutoshi; Tani-Sassa, Chihiro; Yuasa, Sonoka; Kanehira, Saki; Sonobe, Kazunari; Nukui, Yoko; Takeuchi, Hiroaki; Tanimoto, Kousuke; Tanaka, Yukie; Kimura, Akinori; Ichimura, Naoya; Tohda, Shuji.
  • Takatsuki Y; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Takahashi Y; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Nakajima J; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Iwasaki Y; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Nagano K; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Tani-Sassa C; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Yuasa S; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Kanehira S; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Sonobe K; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Nukui Y; Infection Control and Prevention, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Takeuchi H; Department of Molecular Virology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Tanimoto K; Genome Laboratory, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Tanaka Y; Research Core, Institute of Research, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Kimura A; Department of Molecular Microbiology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Ichimura N; Institute of Research, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Tohda S; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
Immun Inflamm Dis ; 11(2): e783, 2023 Feb.
Article in English | MEDLINE | ID: covidwho-2283343
ABSTRACT

BACKGROUND:

Sublineage BA.5 of the SARS-CoV-2 Omicron variant rapidly spread and replaced BA.2 in July 2022 in Tokyo. A high viral load can be a possible cause of high transmissibility. METHODS AND

RESULTS:

The copy numbers of SARS-CoV-2 in nasopharyngeal swab samples obtained from all patients visiting the hospital where this research was conducted were measured using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Viral genotypes were determined using PCR-based melting curve analysis. Next, whole-genome sequencing was performed using approximately one fifth of the samples to verify the viral genotypes determined using PCR. Then, the copy numbers of the BA.1, BA.2, and BA.5 cases were compared. Contrary to expectations, the copy numbers of the BA.5 cases (median 4.7 × 104 copies/µL, n = 291) were significantly (p = .001) lower than those of BA.2 cases (median 1.1 × 105 copies/µL, n = 184). There was no significant difference (p = .44) between the BA.5 and BA.1 cases (median, 3.3 × 104 copies/µL; n = 215).

CONCLUSION:

The results presented here suggest that the increased infectivity of BA.5 is not caused by higher viral loads, but presumably by other factors such as increased affinity to human cell receptors or immune escape due to its L452R mutation.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Topics: Variants Limits: Humans Language: English Journal: Immun Inflamm Dis Year: 2023 Document Type: Article Affiliation country: Iid3.783

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Topics: Variants Limits: Humans Language: English Journal: Immun Inflamm Dis Year: 2023 Document Type: Article Affiliation country: Iid3.783